| 2011 | Bortezomib Induction Followed by ASCT in Patients with Multiple Myeloma: Achievement of Response After Induction and Achieving CR Post-ASCT Are Both Important Prognostic Markers | 문영철 | Meeting Abstract |
| 2017 | BORTEZOMIB-MELPHALAN-PREDNISONE VERSUS MP AS INITIAL TREATMENT FOR VERY ELDERLY PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA | 문영철 | Meeting Abstract |
| 2015 | Calreticulin mRNA expression and clinicopathological characteristics in acute myeloid leukemia | 정화순; 성주명; 허정원; 문영철; 정혜선 | Article |
| 2007 | CD34, RAB20, DLK1, PU.1 and GFI1 mRNA expression in myelodysplastic syndrome | 홍기숙; 정화순; 성주명; 허정원; 문영철 | Meeting Abstract |
| 2009 | CD34, RAB20, PU.1 and GFI1 mRNA expression in myelodysplastic syndrome | 홍기숙; 이미애; 정화순; 성주명; 허정원; 문영철 | Article |
| 2016 | Change of health-related profiles after Imatinib cessation in chronic phase chronic myeloid leukemia patients | 문영철 | Article |
| 2014 | Changes in osteoblastic activity in patient who received bortezomib as second line treatment for plasma cell myeloma: A prospective multicenter study | 문영철 | Article |
| 2011 | Characteristics of myelodysplastic syndrome, unclassifiable by WHO classification 2008 | 정화순; 성주명; 허정원; 문영철 | Letter |
| 2008 | Characterization of phenotypically distinct B-cell subsets and receptor-stimulated mitogen-activated protein kinase activation in human cord blood B cells | 성주명; 이종란; 문영철 | Article |
| 2014 | Chromosome 13 deletion and hypodiploidy on conventional cytogenetics are robust prognostic factors in Korean multiple myeloma patients: Web-based multicenter registry study | 문영철 | Article |
| 2014 | Clinical factors associated with response or survival after chemotherapy in patients with Waldenström macroglobulinemia in Korea | 문영철 | Article |
| 2012 | Clinical features and outcomes of Hodgkin's lymphoma in Korea: Consortium for Improving Survival of Lymphoma (CISL) | 문영철 | Article |
| 2009 | Clinical features and survival outcomes in patients with multiple myeloma: Analysis of web-based data from the korean myeloma registry | 문영철 | Article |
| 2013 | Clinical features and treatment outcome of primary systemic light-chain amyloidosis in Korea: Results of multicenter analysis | 문영철 | Article |
| 2017 | CLINICAL IMPACT BY 24 MONTHS ACCORDING TO BCR/ABL1 TRANSCRIPT LEVEL AT 3 AND 6 MONTHS IN NEWLY DIAGNOSED CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH RADOTINIB 300MG BID OR IMATINIB | 문영철 | Meeting Abstract |
| 2021 | Clinical impact of frailty on treatment outcomes of elderly patients with relapsed and/or refractory multiple myeloma treated with lenalidomide plus dexamethasone | 문영철 | Article |
| 2019 | Clinical implication of renal dysfunction during the clinical course in patients with paroxysmal nocturnal hemoglobinuria: a longitudinal analysis | 문영철 | Article |
| 2015 | Clinical Outcomes and Prognostic Factors of Up-Front Autologous Stem Cell Transplantation in Patients with Extranodal Natural Killer/T Cell Lymphoma | 문영철 | Article |
| 2019 | Clinical Outcomes of Decitabine Treatment for Patients With Lower-Risk Myelodysplastic Syndrome on the Basis of the International Prognostic Scoring System | 문영철 | Article |
| 2016 | CLINICOPATHOLOGIC CHARACTERISTICS ASSOCIATED WITH NATURAL KILLER CELL ACTIVITY BY MEASUREMENT OF INTERFERON-GAMMA IN HEMATOLOGIC MALIGNANCIES | 성주명; 허정원; 문영철 | Meeting Abstract |
| 2015 | CLINICOPATHOLOGIC CHARACTERISTICS OF UNCLASSIFIABLE MYELOPROLIFERATIVE NEOPLASMS | 문영철 | Meeting Abstract |
| 2018 | Clinicopathological Characteristics of Hyperdiploidy with High-Risk Cytogenetics in Multiple Myeloma | 성주명; 허정원; 문영철 | Article |
| 2013 | Comparative analysis between azacitidine and decitabine for the treatment of myelodysplastic syndromes | 성주명; 문영철 | Article |
| 2017 | COMPARISON OF MOLECULAR KINETICS AFTER THE FIRST AND SECOND IMATINIB DISCONTINUATION: RESULTS FROM THE KID STUDY | 문영철 | Meeting Abstract |
| 2011 | Comparison of treatment strategies for patients with intestinal diffuse large B-cell lymphoma: Surgical resection followed by chemotherapy versus chemotherapy alone | 문영철 | Article |
| 2010 | Comparison of various criteria in predicting treatment response and prognosis of patients with myelodysplastic syndrome treated with azacitidine | 문영철 | Article |
| 2021 | Comprehensive analysis of peripheral T-cell and natural killer/T-cell lymphoma in Asian patients: A multinational, multicenter, prospective registry study in Asia | 문영철 | Article |
| 2021 | Comprehensive DNA repair gene expression analysis and its prognostic significance in acute myeloid leukemia | 이미애; 성주명; 허정원; 문영철; 박영미; 정혜선; 박설희; 김이준 | Article |
| 2017 | Comprehensive evaluation of the revised international staging system in multiple myeloma patients treated with novel agents as a primary therapy | 문영철 | Article |
| 2021 | Cutaneous T-cell lymphoma in Asian patients: a multinational, multicenter, prospective registry study in Asia | 문영철 | Article |
